Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Return on Capital Employed (2016 - 2026)

Apyx Medical filings provide 15 years of Return on Capital Employed readings, the most recent being 12.79% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 2341.0% to 12.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 12.79%, a 2341.0% increase, with the full-year FY2025 number at 11.91%, up 1883.0% from a year prior.
  • Return on Capital Employed hit 12.79% in Q4 2025 for Apyx Medical, up from 20.31% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 12.79% in Q4 2025 to a low of 65.17% in Q1 2023.
  • Median Return on Capital Employed over the past 5 years was 29.66% (2023), compared with a mean of 33.74%.
  • Biggest five-year swings in Return on Capital Employed: tumbled -3647bps in 2023 and later soared 3682bps in 2024.
  • Apyx Medical's Return on Capital Employed stood at 26.25% in 2021, then tumbled by -115bps to 56.54% in 2022, then surged by 46bps to 30.49% in 2023, then fell by -19bps to 36.2% in 2024, then skyrocketed by 65bps to 12.79% in 2025.
  • The last three reported values for Return on Capital Employed were 12.79% (Q4 2025), 20.31% (Q3 2025), and 25.32% (Q2 2025) per Business Quant data.